1994
DOI: 10.3892/ijo.5.5.1049
|View full text |Cite
|
Sign up to set email alerts
|

Soluble Fragments of E-Cadherin Cell-Adhesion Molecule Increase in Urinary-Excretion of Cancer-Patients, Potentially Indicating Its Shedding From Epithelial Tumor-Cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
16
0

Year Published

1997
1997
2015
2015

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 15 publications
(16 citation statements)
references
References 0 publications
0
16
0
Order By: Relevance
“…Also, the loss of E-cadherin function is a causal factor in the promotion of invasion and metastasis. 33 High levels of soluble E-cadherin in serum 34 and urine 35 of patients with cancer and coexpression of MMPs and E-cadherin cell metastasis studies 36 support that statement. Based on animal studies, and the role of MMPs and E-cadherin in modulation mechanism of cancer invasion, we hypothesized that MMP-2, MMP-9, and E-cadherin can be expressed in the endometrium during the implantation window and are involved in the implantation process in women.…”
Section: Introductionmentioning
confidence: 93%
“…Also, the loss of E-cadherin function is a causal factor in the promotion of invasion and metastasis. 33 High levels of soluble E-cadherin in serum 34 and urine 35 of patients with cancer and coexpression of MMPs and E-cadherin cell metastasis studies 36 support that statement. Based on animal studies, and the role of MMPs and E-cadherin in modulation mechanism of cancer invasion, we hypothesized that MMP-2, MMP-9, and E-cadherin can be expressed in the endometrium during the implantation window and are involved in the implantation process in women.…”
Section: Introductionmentioning
confidence: 93%
“…In patients with cancer, high levels of circulating ICAM-1 have been found to be associated with the presence of liver metastases in gastric, colonic, gall bladder and pancreatic cancer (Tsujisaki et al, 1991), with poor survival of patients with malignant melanoma (Harning et al, 1991;Altomonte et al, 1992;Kageshita et al, 1992Kageshita et al, , 1993Viac et al, 1993) and correlated with disease stage and progression in Hodgkin's disease (Gruss et al, 1993). Soluble forms of E-cadherin have been identified in serum and urine of normal individuals and patients with cancer and cutaneous diseases (Katayama et al, 1994b;Banks et al, 1995;Matsuyoshi et al, 1995).…”
mentioning
confidence: 99%
“…The technique for in situ visualization of DNA fragmentation was carried out according to the method described by Mori et al (16), which was a modification of the one developed by Gavrieli et al (17) -free insulin, transferrin, and selenium/Dulbecco's modified Eagle's medium, which was supplemented with high (1 mM) or low (0.09 mM) levels of divalent cations by addition of CaCl 2 and MgCl 2 at the indicated concentrations. To study the effect of blocking antibody to E-cadherin, HSC-3 cells were seeded at 6 ϫ 10 5 cells/plate in the presence of mouse anti-human E-cadherin mAb (clone SHE78-7, Zymed Laboratories) at 1 g/ml and incubated for up to 72 h (18,19). Mouse IgG added to monolayer, single cell, and MCA cultures at 1 g/ml was used as control.…”
mentioning
confidence: 99%